annual meeting program - American Society of Clinical Oncology

MONDAY
Monday, June 7, 2010
NCI Community Cancer Centers Program (NCCCP): A New Paradigm for
Clinical Trials in the Community Setting
Location: S404
CME credit: 1.25
Track(s): Clinical Trials; Practice Management and Information Technology; Professional
Developmental
Mark Krasna, MD—Chair
St. Joseph Medical Center
Multidisciplinary Cancer Care as the Paradigm for Prospective Case Management and Clinical
Trial Accrual in the Community Setting
John E. Niederhuber, MD
National Cancer Institute
The Vision of the NCCCP and Its Potential Impact on Community Cancer Care in the Future
Nicholas J. Petrelli, MD
Helen F. Graham Cancer Center
Disparities and Community Outreach in the NCCCP
Response-based Therapy: A Personalized Approach to Pediatric Hodgkin
Lymphoma
Location: S504
CME credit: 1.25
Track(s): Pediatric Oncology; Lymphoma and Plasma Cell Disorders
Cindy L. Schwartz, MD—Chair
Brown Medical School
Optimizing Chemotherapy: Response and Biology
Louis S. Constine, MD
James P. Wilmot Cancer Center
RT or not RT: That Is the Question!
Stephan Voss, MD, PhD
Children’s Hospital Boston
Functional Imaging and Hodgkin Lymphoma
The Biology of Leukemia and Myeloproliferative Disorders: Implications for
Treatment
Location: E354b
CME credit: 1.25
Track(s): Leukemia, Myelodysplasia, and Transplantation
Olatoyosi Odenike, MD—Chair
University of Chicago
Epigenetic and Other Rational Therapeutic Approaches in MPD
Catriona Jamieson, MD, PhD
University of California, San Diego
JAK 2 and Related Mutations in Myeloid Neoplasms: Biology and Therapeutic Implications
Guido Marcucci, MD
The Ohio State University Medical Center
MicroRNA in AML and CLL: What Does It Mean?
390